Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.20
+0.21 (2.34%)
At close: Aug 8, 2025, 4:00 PM
9.31
+0.11 (1.20%)
After-hours: Aug 8, 2025, 7:54 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $202.43 million as of August 8, 2025. Its market cap has increased by 494.48% in one year.
Market Cap
202.43M
Enterprise Value
197.70M
1-Year Change
494.48%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $202.43M, an increase of 220.78%. That is a compound annual growth rate of 21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 202.43M | 179.94% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |